ClinicalTrials.gov
ClinicalTrials.gov Menu

Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial (UMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00936195
Recruitment Status : Withdrawn (faillure to obtain insurance because of refusal from insurance companies)
First Posted : July 9, 2009
Last Update Posted : February 15, 2012
Sponsor:
Collaborators:
Gilead Sciences
Merck Sharp & Dohme Corp.
GlaxoSmithKline
Abbott
Information provided by (Responsible Party):
French National Agency for Research on AIDS and Viral Hepatitis

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : January 2013
  Estimated Study Completion Date : June 2013